Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


30 Ekim 2021, Cumartesi, 00:08 Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021
For frontline workers, COVID-19 mRNA vaccines, Pfizer-BioNTech and Moderna, are effective against viral infection, but less effective during Delta variant spread.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=426097

30 Ekim 2021, Cumartesi, 00:08 SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021
COVID-19 vaccine effectiveness, reinfection, and hospitalization in fully, partially, and unvaccinated people during the Delta variant in Los Angeles County, California.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=426098

30 Ekim 2021, Cumartesi, 00:08 New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425927

30 Ekim 2021, Cumartesi, 00:08 Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021
COVID-19 vaccine effectiveness against hospitalizations was stable for people who received 2 doses, and vaccines remained effective among people with risk for severe COVID-19.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425928

30 Ekim 2021, Cumartesi, 00:08 Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021
COVID-19 mRNA vaccines, Pfizer-BioNTech and Moderna, are effective against infection among nursing home residents, but effectiveness declined in recent months.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425953

30 Ekim 2021, Cumartesi, 00:08 Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021
This report describes the circulation of influenza and other respiratory viruses during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=424882

30 Ekim 2021, Cumartesi, 00:08 Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic - Nine States, Nigeria, March 31, 2019-September 30, 2020
This report describes a program that increased the number of persons with HIV infections who initiated antiretroviral therapy before and during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418930

30 Ekim 2021, Cumartesi, 00:08 Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021
This report describes adolescent COVID-19 vaccination acceptance and the factors that would increase adolescent vaccination, including information about COVID-19 vaccine safety and effectiveness in teenagers.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=424341

30 Ekim 2021, Cumartesi, 00:08 SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021
This report describes a COVID-19 B.1.617.2 (Delta) variant outbreak in a gymnastics facility.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=424342

30 Ekim 2021, Cumartesi, 00:08 COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020−February 14, 2021
This report describes persons who received both doses of a two-dose COVID-19 vaccination series and the interval between the first and second dose among those who were vaccinated.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418592